Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |